hydroxychloroquine has been researched along with Cicatrization in 13 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Cicatrization: The formation of fibrous tissue in the place of normal tissue during the process of WOUND HEALING. It includes scar tissue formation occurring in healing internal organs as well as in the skin after surface injuries.
Excerpt | Relevance | Reference |
---|---|---|
"Subgroup analyses for the response to antimalarials considering CLE subtypes, type, and dosage of antimalarials could not be performed because of the lack of available data." | 2.52 | Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. ( Amoura, Z; Arnaud, L; Barete, S; Chasset, F; Francès, C, 2015) |
"One patient had hair loss of the upper cutaneous lip." | 1.46 | Frontal fibrosing alopecia among men: A clinicopathologic study of 7 cases. ( Camilleri, MJ; Chaudhry, HM; Tolkachjov, SN; Torgerson, RR, 2017) |
"FFA is an increasingly common form of scarring hair loss, but the origin remains unknown." | 1.39 | Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University. ( Bazakas, A; Ladizinski, B; Olsen, EA; Selim, MA, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 6 (46.15) | 2.80 |
Authors | Studies |
---|---|
Collins, M | 1 |
Ali, S | 1 |
Wiss, IP | 1 |
Senna, MM | 3 |
Collins, MS | 1 |
Ezemma, O | 2 |
Devjani, S | 2 |
Klein, EJ | 1 |
Karim, M | 1 |
Lo Sicco, K | 1 |
Shapiro, J | 2 |
Jothishankar, B | 1 |
Kelley, KJ | 1 |
Starace, M | 1 |
Orlando, G | 1 |
Alessandrini, A | 1 |
Baraldi, C | 1 |
Bruni, F | 1 |
Piraccini, BM | 1 |
Shaw, KS | 1 |
Yin, L | 1 |
Shah, JK | 1 |
Sally, RA | 1 |
Svigos, KS | 1 |
Adotama, PU | 1 |
Tuan, HH | 1 |
Betensky, RA | 1 |
Lo Siccoa, KI | 1 |
Tolkachjov, SN | 1 |
Chaudhry, HM | 1 |
Camilleri, MJ | 1 |
Torgerson, RR | 1 |
Atzori, L | 1 |
Robustelli Test, E | 1 |
Ferreli, C | 1 |
Pilloni, L | 1 |
Rongioletti, F | 1 |
Chasset, F | 1 |
Francès, C | 1 |
Barete, S | 1 |
Amoura, Z | 1 |
Arnaud, L | 1 |
Chiang, C | 1 |
Sah, D | 1 |
Cho, BK | 1 |
Ochoa, BE | 1 |
Price, VH | 1 |
Ladizinski, B | 1 |
Bazakas, A | 1 |
Selim, MA | 1 |
Olsen, EA | 1 |
Park, AJ | 1 |
Webster, GF | 1 |
Penne, RB | 1 |
Raber, IM | 1 |
Bergner, T | 1 |
Braun-Falco, O | 1 |
2 reviews available for hydroxychloroquine and Cicatrization
Article | Year |
---|---|
Adverse effects of hydroxychloroquine use in patients with cicatricial alopecia: A systematic review.
Topics: Alopecia; Cicatrix; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Iat | 2023 |
Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature.
Topics: Antimalarials; Causality; Chloroquine; Cicatrix; Comorbidity; Drug Resistance; Humans; Hydroxychloro | 2015 |
11 other studies available for hydroxychloroquine and Cicatrization
Article | Year |
---|---|
Retrospective review of adverse events associated with oral hydroxychloroquine use in patients with cicatricial alopecia.
Topics: Alopecia; Cicatrix; Hair; Humans; Hydroxychloroquine; Retrospective Studies | 2023 |
Reply to "Response to Collins et al.'s 'Retrospective review of adverse events associated with oral hydroxychloroquine use in patients with cicatricial alopecia'".
Topics: Alopecia; Cicatrix; Humans; Hydroxychloroquine; Retrospective Studies | 2022 |
Response to the study by Collins et al "Retrospective review of adverse events associated with oral hydroxychloroquine use in patients with cicatricial alopecia."
Topics: Alopecia; Cicatrix; Humans; Hydroxychloroquine; Lichen Planus; Retrospective Studies | 2022 |
Diffuse variants of scalp lichen planopilaris: Clinical, trichoscopic, and histopathologic features of 40 patients.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Adult; Aged; Alopecia A | 2020 |
COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients.
Topics: Alopecia; Antiviral Agents; Cicatrix; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics | 2021 |
Frontal fibrosing alopecia among men: A clinicopathologic study of 7 cases.
Topics: Adult; Aged; Alopecia; Anti-Inflammatory Agents; Cheek; Cicatrix; Clobetasol; Dermatologic Agents; E | 2017 |
Impressive oral lichen planus progression to invasive squamous cell carcinoma in a three months lapse.
Topics: Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cicatrix; Disease Progression; Follow-Up | 2019 |
Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system.
Topics: Adult; Alopecia; Cicatrix; Female; Fibrosis; Humans; Hydroxychloroquine; Lichen Planus; Male; Middle | 2010 |
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Anti-Bacterial Agents; Azasteroids; Cicatrix; D | 2013 |
Porphyria cutanea tarda presenting as cicatricial conjunctivitis.
Topics: Administration, Oral; Adult; Cicatrix; Conjunctivitis; Dermatologic Agents; Humans; Hydroxychloroqui | 2002 |
Pseudopelade of Brocq.
Topics: Adolescent; Adult; Alopecia; Child; Cicatrix; Female; Humans; Hydroxychloroquine; Male | 1991 |